IMarkHD: in Vivo Longitudinal Imaging of HD Pathology — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IMarkHD: in Vivo Longitudinal Imaging of HD Pathology — Stella

Home/Huntington Disease/

View on ClinicalTrials.gov

Recruiting

Back to Huntington Disease trials

Trial locations(1 site)

United Kingdom

King's College London, London, England

Key details

Sponsor

King's College London

Collaborators

CHDI Foundation, Inc.

Enrollment target

~113 participants

Started

July 2021

Primary completion

June 2027

Age range

21 Years – 75 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.